Calyxt (NASDAQ:CLXT) posted its quarterly earnings data on Monday. The company reported ($0.26) EPS for the quarter, missing analysts’ consensus estimates of ($0.25) by ($0.01), Fidelity Earnings reports. Calyxt had a negative return on equity of 33.08% and a negative net margin of 6,256.67%.
CLXT stock opened at $17.00 on Wednesday. Calyxt has a twelve month low of $8.83 and a twelve month high of $22.32. The stock has a market cap of $576.20 million, a P/E ratio of -15.18 and a beta of 2.70. The company has a debt-to-equity ratio of 0.17, a quick ratio of 15.01 and a current ratio of 15.01.
In related news, insider Daniel F. Voytas sold 3,977 shares of Calyxt stock in a transaction dated Monday, February 25th. The stock was sold at an average price of $16.00, for a total transaction of $63,632.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Daniel F. Voytas sold 8,170 shares of Calyxt stock in a transaction dated Friday, February 1st. The stock was sold at an average price of $13.00, for a total value of $106,210.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 19,791 shares of company stock worth $261,718. 2.80% of the stock is owned by company insiders.
A number of research firms have recently commented on CLXT. Zacks Investment Research upgraded Calyxt from a “sell” rating to a “hold” rating in a research note on Tuesday. Citigroup lifted their price objective on Calyxt from $13.00 to $16.00 and gave the stock a “neutral” rating in a research note on Wednesday, February 27th. National Securities began coverage on Calyxt in a research note on Wednesday, March 6th. They issued a “buy” rating and a $35.00 price objective on the stock. Finally, Jefferies Financial Group reiterated a “buy” rating and issued a $27.00 price objective on shares of Calyxt in a research note on Thursday, November 15th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Calyxt currently has an average rating of “Buy” and a consensus price target of $21.80.
COPYRIGHT VIOLATION NOTICE: This piece of content was published by Highlight Press and is the sole property of of Highlight Press. If you are accessing this piece of content on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright laws. The original version of this piece of content can be accessed at https://highlightpress.com/2019/03/13/calyxt-clxt-posts-earnings-results-misses-estimates-by-0-01-eps.html.
Calyxt Company Profile
Calyxt, Inc, a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for plants in the United States. It engages in the development of high oleic soybeans, high fiber wheat, herbicide tolerant wheat, powdery mildew resistant wheat, improved oil composition canola, herbicide tolerant canola, improved quality alfalfa and herbicide tolerant alfalfa, late blight resistant potatoes, cold storable/reduced browning potatoes, improved protein composition soybeans, drought tolerant soybeans, herbicide tolerant soybeans, and improved yield soybeans.
Recommended Story: How do candlesticks reflect price movement?
Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.